再生(生物学)
肺泡巨噬细胞
巨噬细胞
过氧化物酶体
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
极限(数学)
生物
2019年冠状病毒病(COVID-19)
病毒学
细胞生物学
病理
医学
生物化学
数学
数学分析
疾病
基因
传染病(医学专业)
体外
作者
Xiaoqin Wei,Wei Qian,Harish Narasimhan,T. K. Chan,Xue Liu,Mohd Arish,Scott Young,Chaofan Li,In Su Cheon,Qing Yu,Gislane de Almeida Santos,Xiaoyu Zhao,Eric V. Yeatts,Olivia J. Spear,M. -Q. Yi,Tanyalak Parimon,Yinshan Fang,Young S. Hahn,Timothy N. J. Bullock,Lindsay Somerville
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2025-03-06
卷期号:387 (6738)
标识
DOI:10.1126/science.adq2509
摘要
Peroxisomes are vital but often overlooked metabolic organelles. We found that excessive interferon signaling remodeled macrophage peroxisomes. This loss of peroxisomes impaired inflammation resolution and lung repair during severe respiratory viral infections. Peroxisomes were found to modulate lipid metabolism and mitochondrial health in a macrophage type-specific manner and enhanced alveolar macrophage-mediated tissue repair and alveolar regeneration after viral infection. Peroxisomes also prevented excessive macrophage inflammasome activation and IL-1β release, limiting accumulation of KRT8high dysplastic epithelial progenitors following viral injury. Pharmacologically enhancing peroxisome biogenesis mitigated both acute symptoms and post-acute sequelae of COVID-19 (PASC) in animal models. Thus, macrophage peroxisome dysfunction contributes to chronic lung pathology and fibrosis after severe acute respiratory syndrome coronavirus 2 infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI